Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2025-12-24 @ 3:05 PM
NCT ID:
NCT02315859
Eligibility Criteria:
Inclusion Criteria:
* 1\. Patients referred to elective percutaneous coronary angiography
* Stable cardio-pulmonary conditions
* Sinus rhythm
* Written informed consent to participate to the study
Exclusion Criteria
* Patients referred to emergency coronary intervention
* 2\. Prior myocardial infarction, wall-motion-abnormalities, stenosis ≥50%
* Prior cardiac surgery
* More than mild left-sided valve disease
* Documented pulmonary disease leading to dyspnea NYHA II or more, including history of asthma bronchiale
* Any restrictive LV filling pattern without eccentric LV hypertrophy, such as in infiltrative myocardial diseases
* Pericardial diseases, including prior pericardiotomy and pericardial effusions.
* Pacemaker, implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy device (CRT)
* Known adverse reactions to Dobutamin or Esmolol
* Women who are pregnant or breast feeding (β-HCG \> 10 IU/L)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02315859
Study Brief:
Protocol Section:
NCT02315859